go-v.orgdoi

Autoimmunity and lung transplantation

Ankit Bharat, Thalachallour Mohanakumar · Frontiers in Bioscience-Elite · 2012

  • DOI 10.2741/e549
  • Publisher Frontiers Media
  • Type review
  • Issued 2012

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Frontiers in Bioscience-Elite · Frontiers Media · review · 2012

Abstract

Lung transplantation is a viable treatment option for a variety of end-stage lung diseases. Since the first successful human lung transplant about 20 years ago, tremendous progress has been made in this field. However, lung allografts have the poorest long term survival compared to other solid organs. The predominant reason for this is the development of chronic rejection, also known as bronchiolitis obliterans syndrome (BOS). Although the traditional view supports alloimmunity as the major cause of chronic rejection, emerging evidence reveals a complex interplay of multiple etiologies including peri-operative stressors, inflammation, and autoimmunity along with alloimmunity.

Identification of autoimmunity in the pathogenesis of BOS is an exciting recent finding in lung transplantation and promises to introduce novel strategies for future therapeutic interventions. In this review, we discuss recent studies and concepts related to the role of autoimmunity in the development of BOS.

Open the resolved locator · 10.2741/e549

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 15:31 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.2741/e549
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.